301156.SHE Shanghai Menon Animal Nutrition Technology Co. Ltd.
- Market cap
- CNY 1.83B
- P/E
- 36.9x
- P/B
- 2.52x
- ROE
- 5.0%
- Dividend yield
- 2.46%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 301156.SHE undervalued?
Graham number301156.SHE trades 103.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shanghai Menon Animal Nutrition Technology Co. Ltd. fundamental analysis
No fundamental analysis for Shanghai Menon Animal Nutrition Technology Co. Ltd. yet.
Shanghai Menon Animal Nutrition Technology Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shanghai Menon Animal Nutrition Technology Co. Ltd.
Shanghai Menon Animal Nutrition Technology Co., Ltd. engages in the research and development, production, and sale of feed additives and enzymatic protein feed raw materials in China and internationally. The company offers swine products, such as feed flavoring and feed sweeteners; combination enzymatic protein digestion; feed acidifier; and antibacterial organic acid preparations, sodium butyrate, new generation of butyric acid preparations and supramolecular protective ess…
Full company profileShanghai Menon Animal Nutrition Technology Co. Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shanghai Menon Animal Nutrition Technology Co. Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 266M | 280M | 421M | 546M | 483M | 504M | 490M | 561M | 655M |
| Gross Profit | 92.4M | 107M | 151M | 160M | 139M | 150M | 140M | 172M | 193M |
| Operating Income | 28.2M | 38.9M | 77.0M | 79.2M | 58.5M | 66.7M | 54.5M | 62.0M | 67.0M |
| EBITDA | 37.1M | 48.5M | 85.5M | 89.6M | 68.9M | 89.5M | 79.1M | 87.8M | 39.0M |
| Net Income | 25.6M | 34.4M | 66.7M | 70.6M | 52.5M | 63.0M | 49.6M | 54.8M | 36.1M |
| EPS | 0.23 | 0.31 | 0.61 | 0.65 | 0.41 | 0.43 | 0.34 | 0.30 | 0.20 |
| Balance Sheet | |||||||||
| Total Assets | 236M | 258M | 347M | 530M | 887M | 839M | 790M | 829M | 810M |
| Total Liabilities | 40.6M | 41.6M | 93.0M | 206M | 105M | 39.7M | 45.4M | 98.8M | 80.8M |
| Shareholders' Equity | 196M | 217M | 254M | 324M | 782M | 799M | 745M | 730M | 729M |
| Cash & Short-term Investments | 21.3M | 80.3M | 68.1M | 126M | 419M | 390M | 301M | 186M | 138M |
| Total Debt | 10.0M | 10.5M | 11.0M | 111M | 3.99M | 227K | 155K | - | - |
| Cash Flow | |||||||||
| Operating Cash Flow | 17.7M | 50.6M | 51.2M | 90.0M | 42.1M | 60.0M | 67.2M | 66.5M | - |
| Capital Expenditure | 11.1M | 8.20M | 34.0M | 126M | 49.7M | 38.5M | 55.9M | 118M | 41.0M |
| Free Cash Flow | 6.61M | 42.4M | 17.1M | -35.8M | -7.63M | 21.6M | 11.2M | -51.4M | -54.9M |
| Ratios | |||||||||
| ROE | 13.1% | 15.8% | 26.3% | 21.8% | 6.7% | 7.9% | 6.7% | 7.5% | 5.0% |
| ROA | 10.9% | 13.3% | 19.2% | 13.3% | 5.9% | 7.5% | 6.3% | 6.6% | 4.5% |
| Net Profit Margin | 9.6% | 12.3% | 15.9% | 12.9% | 10.9% | 12.5% | 10.1% | 9.8% | 5.5% |
| Debt to Equity | 0.05x | 0.05x | 0.04x | 0.34x | 0.01x | 0.00x | 0.00x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Shanghai Menon Animal Nutrition Technology Co. Ltd. dividends
- Dividend yield
- 2.46%
- Forward dividend
- 0.28 CNY
- Payout ratio
- 82.2%
- Ex-dividend date
- May 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 45.1M | 0.25 | 82.2% |
| 2024 | CNY 60.9M | 0.42 | 122.7% |
| 2023 | CNY 48.0M | 0.33 | 76.2% |
| 2022 | CNY 3.08M | 0.02 | 5.9% |
| 2021 | CNY 2.17M | 0.02 | 3.1% |
| 2020 | CNY 30.4M | 0.28 | 45.6% |
| 2019 | CNY 15.5M | 0.14 | 45.2% |
| 2018 | 18.7M | 0.17 | 72.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.3:1 on May 29, 2026.
Who owns Shanghai Menon Animal Nutrition Technology Co. Ltd.
- Insiders 68.12%
- Institutions 4.52%
- Public & others 27.36%
- Shares outstanding 184M
- Free float 57.8M
Shanghai Menon Animal Nutrition Technology Co. Ltd. company profile
- Company name
- Shanghai Menon Animal Nutrition Technology Co. Ltd.
- Ticker
- 301156.SHE
- ISIN
- CNE100005DR2
- Exchange
- Shenzhen Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 461
- Fiscal year end
- December
- Address
- No. 151 Lihong Road, Shanghai, China, 201807
- Phone
- 86 21 5954 6758
- Website
- sinomenon.com
About Shanghai Menon Animal Nutrition Technology Co. Ltd.
Shanghai Menon Animal Nutrition Technology Co., Ltd. engages in the research and development, production, and sale of feed additives and enzymatic protein feed raw materials in China and internationally. The company offers swine products, such as feed flavoring and feed sweeteners; combination enzymatic protein digestion; feed acidifier; and antibacterial organic acid preparations, sodium butyrate, new generation of butyric acid preparations and supramolecular protective essential oils, embedded multilayer coated zinc oxide, and cottonseed enzymatic hydrolysate. It also provides ruminant products, including highly concentrated slow-release nitrogen source; rumen-protected choline chloride, rumen-protected niacin, and coated ammonium chloride; rumen-passed glucose; and rumen-protected methionine and rumen-protected lysine. In addition, the company offers microcapsule acidifier, liquid acidifier, plant essential oils and organic acids, organic acids and plant essential oils, solid plant essential oils, and emulsifier. Its products are used for pigs, ruminants, poultry, aquatic animals, and pets. Shanghai Menon Animal Nutrition Technology Co., Ltd. was founded in 1997 and is based in Shanghai, China.
Shanghai Menon Animal Nutrition Technology Co. Ltd. management
5- Mr. Wei HongChairman of the Board & GM · born 1968
- Ms. Qian ZhouFinancial Director & Accounting Supervisor · born 1978
- Mr. Ying XiongDirector & Deputy GM · born 1970
- Ms. Ji Hong WangDirector & Deputy GM · born 1969
- Ms. Weiwei ZhangDeputy GM & Board Secretary · born 1981